24
19
1
49
2
2
2c
1b
1d
18
89
31
1d
2 29
1d
25
31
Ashish P Thakrar, MD
60Assistant Professor of Medicine (General Internal Medicine)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
49
4
3
3
1d
49
3600 Civic Center Boulevard
37 7th Floor CHT07-100B
Philadelphia, PA 19104
26
37 7th Floor CHT07-100B
Philadelphia, PA 19104
35
a1
12
18
Publications
23 a
3
2
29
23 a
Links
b8 Search PubMed for articles
d
4
b
1f
b8 Search PubMed for articles
d
13
Education:
21 7 BS 16 (Economics) c
33 Carnegie Mellon University, 2012.
21 8 BFA 1e (Piano Performance) c
33 Carnegie Mellon University, 2012.
21 7 MD 15 (Medicine) c
46 University of Pennsylvania School of Medicine, 2017.
21 7 MS 23 (Health Policy Research) c
33 University of Pennsylvania, 2023.
c
3
3
21
21 7 BS 16 (Economics) c
33 Carnegie Mellon University, 2012.
21 8 BFA 1e (Piano Performance) c
33 Carnegie Mellon University, 2012.
21 7 MD 15 (Medicine) c
46 University of Pennsylvania School of Medicine, 2017.
21 7 MS 23 (Health Policy Research) c
33 University of Pennsylvania, 2023.
c
1f
Post-Graduate Training
24 6c Post-Baccalaureate Premedical Program, Johns Hopkins University, Baltimore, MD, 2012-2013.
24 69 Resident, Internal Medicine, Johns Hopkins Hospital Osler Medical Residency, 2017-2020.
24 6d Fellow, Addiction Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, 2020-2021.
24 5e National Clinical Scholar Program, University of Pennsylvania, 2021-Present.
24 58 MSc, Health Policy Research, University of Pennsylvania, 2021-Present.
c
3
25
24 6c Post-Baccalaureate Premedical Program, Johns Hopkins University, Baltimore, MD, 2012-2013.
24 69 Resident, Internal Medicine, Johns Hopkins Hospital Osler Medical Residency, 2017-2020.
24 6d Fellow, Addiction Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, 2020-2021.
24 5e National Clinical Scholar Program, University of Pennsylvania, 2021-Present.
24 58 MSc, Health Policy Research, University of Pennsylvania, 2021-Present.
c
17
Certifications
28 46 American Board of Internal Medicine Certified, 2020.
28 64 Addiction Medicine Certified from the American Board of Preventive Medicine, 2021.
c
3
8d
Permanent link28 46 American Board of Internal Medicine Certified, 2020.
28 64 Addiction Medicine Certified from the American Board of Preventive Medicine, 2021.
c
2 29
21
1e
1d
24
2b
29
27
23
142 Zhang A, Barnes J, Sherman J, O'Donnell N, Velez R, Huo S, Thakrar AP, Lowenstein P, Perrone J, Kilaru AS: Linkage to Outpatient Methadone Treatment from the Emergency Department and Hospital. Academic Emergency Medicine 32(11): 1251-1254, Nov 2025.
c5 Thakrar AP.: Rapid Initiation of Extended-Release Buprenorphine-Evidence and Barriers. JAMA Netw Open 8: e2537331, Oct 2025.
16e Davis MH, Chertok J, Aronowitz S, French R, Perrone J, Thakrar AP, Huo S, Wilson JD, Bhadra-Heintz N, Lesniak L, Hecker A, Tolbert J, Lowenstein M.: Caring for Hospitalized Patients with Substance Use Disorders: An Interprofessional Needs Assessment Survey. Am J Med Open 14: 100116, Aug 2025.
149 Thakrar AP, Zwiebel SJ, Christine PJ, Spadaro A, Davis MH, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M.: Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series. Drug Alcohol Depend 272: 112681, Jul 2025.
e8 Unsihuay D, Wang P, Milone M, Thakrar AP, Perrone J: Performance of a Xylazine Test Strip in Urine Biospecimens. Journal of Addiction Medicine 19(4), Jul 2025.
152 Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R, Thakrar AP, Dickinson DT, Berg D, Preston A, David MZ, Perrone J, Talati N, Degnan KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12: ofaf299, May 2025.
f6 Nessen SJ, Thakrar AP, Perrone J, Xu L, McFadden R, Lowenstein M: Hospital Security Searches Among Patients With Substance-Related Encounters. JAMA Netw Open 8(3), Mar 2025.
103 Berk J, Rose M, Thakrar AP.: Low-Dose Initiations of Buprenorphine in the Fentanyl Era-A Search for Evidence-Based Approaches to an Evolving Crisis. JAMA Netw Open 8: e2456261, Jan 2025.
15f French R, McFadden R, Lowenstein M, O'Donnell N, Perrone J, Aronowitz S, Thakrar AP, Schachter A, Turi E, Compton P.: A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital. J Subst Use Addict Treat Jan 2025.
2c
7
1d
1f
Selected Publications
11f Yu-Chia H, Thakrar AP, Leonard CE, Lowenstein M, Brensinger CM, Bilker WB, Bogar KF, Hennessy S: Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees. JAMA Health Forum 6(11), Nov 2025.142 Zhang A, Barnes J, Sherman J, O'Donnell N, Velez R, Huo S, Thakrar AP, Lowenstein P, Perrone J, Kilaru AS: Linkage to Outpatient Methadone Treatment from the Emergency Department and Hospital. Academic Emergency Medicine 32(11): 1251-1254, Nov 2025.
c5 Thakrar AP.: Rapid Initiation of Extended-Release Buprenorphine-Evidence and Barriers. JAMA Netw Open 8: e2537331, Oct 2025.
16e Davis MH, Chertok J, Aronowitz S, French R, Perrone J, Thakrar AP, Huo S, Wilson JD, Bhadra-Heintz N, Lesniak L, Hecker A, Tolbert J, Lowenstein M.: Caring for Hospitalized Patients with Substance Use Disorders: An Interprofessional Needs Assessment Survey. Am J Med Open 14: 100116, Aug 2025.
149 Thakrar AP, Zwiebel SJ, Christine PJ, Spadaro A, Davis MH, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M.: Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series. Drug Alcohol Depend 272: 112681, Jul 2025.
e8 Unsihuay D, Wang P, Milone M, Thakrar AP, Perrone J: Performance of a Xylazine Test Strip in Urine Biospecimens. Journal of Addiction Medicine 19(4), Jul 2025.
152 Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R, Thakrar AP, Dickinson DT, Berg D, Preston A, David MZ, Perrone J, Talati N, Degnan KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12: ofaf299, May 2025.
f6 Nessen SJ, Thakrar AP, Perrone J, Xu L, McFadden R, Lowenstein M: Hospital Security Searches Among Patients With Substance-Related Encounters. JAMA Netw Open 8(3), Mar 2025.
103 Berk J, Rose M, Thakrar AP.: Low-Dose Initiations of Buprenorphine in the Fentanyl Era-A Search for Evidence-Based Approaches to an Evolving Crisis. JAMA Netw Open 8: e2456261, Jan 2025.
15f French R, McFadden R, Lowenstein M, O'Donnell N, Perrone J, Aronowitz S, Thakrar AP, Schachter A, Turi E, Compton P.: A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital. J Subst Use Addict Treat Jan 2025.
2c
44
23
Back to Top
1b
1d
18